Roflumilast Foam for Seborrheic Dermatitis: Read STRATUM and the Label

If scalp flakes or a facial rash become an appearance concern while you use a GLP-1 medicine, describe the skin problem to a dermatologist. Roflumilast foam has evidence for a diagnosed inflammatory skin condition. That evidence does not establish a treatment for GLP-1-related shedding.

What STRATUM called success

Blauvelt and colleagues' 2024 phase 3 trial randomly assigned people with seborrheic dermatitis, in a 2:1 ratio, to roflumilast foam 0.3% or vehicle foam once daily for eight weeks. Vehicle means the foam base without the active drug. The primary outcome required an investigator rating of clear or almost clear plus at least a two-point improvement from baseline. At week eight, 79.5% with roflumilast and 58.0% with vehicle met that outcome.[2]

This is a proportion meeting a combined threshold, not a 79.5% reduction in every participant's rash. The trial's eight-week treatment period also limits what it establishes about a chronic condition's longer course. PubMed's disclosures include Arcutis research funding, author financial relationships and employee authors. This article reviewed the abstract and disclosures, not the full methods.[2]

The U.S. label lists 304 participants randomized to roflumilast and 153 to vehicle in STRATUM. Its table notes that the success analysis used multiple imputation, a statistical method for addressing missing values.[1] These percentages should not be presented as simple counts of participants with every observation available.

Name the feature you want reviewed

AAD lists reducing rash and scales, easing itch and swelling, and preventing flare-ups among treatment goals. It describes getting the condition under control before changing treatment to maintain results.[3]

Write your concern in observable terms. For example: “scales collect along the hairline,” “itch interrupts work,” or “the patches near my eyebrows bother me in photographs.” If shedding is also present, put it on a separate line. Ask what assessment each concern needs and which finding will be used to review the treatment.

A better-looking hairline photograph does not count the hairs being shed or identify their cause. Bring both concerns to the clinician without requiring a single product to explain or treat them all.

Review health history and medicines

The foam is contraindicated with moderate to severe liver impairment, classified as Child-Pugh B or C. Its label calls for an interaction review with certain systemic enzyme inhibitors and oral contraceptives containing gestodene and ethinyl estradiol. These can increase roflumilast exposure and adverse reactions; this is not a statement that every contraceptive interacts. Discuss pregnancy and breastfeeding too. Listed seborrheic-dermatitis reactions include common-cold symptoms, nausea and headache.[1]

Have the pharmacist check the exact medicines and supplements you use, including occasional products. If a symptom already occurs with another treatment, note when it started. The team needs that history before assigning a cause to something that happens after a new prescription.

Include the foam's handling instructions

The propellants are flammable. The label says to avoid fire, flame and smoking during and immediately after application.[1] Read the supplied instructions with the pharmacist and ask how to fit them into your routine. Do not guess at a safe waiting interval from a social post.

If someone helps with scalp care, make sure they have the same instructions. Keep the medicine in its own packaging so its formulation and precautions remain available. A plain container or a shared bathroom shelf can make it harder to identify which directions belong to which product.

Set the follow-up question before starting

Ask when the prescriber wants to assess response and what to do if symptoms worsen or a reaction occurs. Follow the prescribed plan rather than copying a trial schedule. If photographs are requested, agree on lighting and timing, and record itch separately from appearance.

Bring a short account of what changed and what remains difficult. For another cause of scalp discomfort that can affect a hair routine, see the site's scalp psoriasis care discussion. The sources here do not establish that a GLP-1 medicine caused either condition.

Printed book

How to Keep Your Face on GLP-1

$12.95 + free shipping

Order Now

✓ 30 day money back guarantee

This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.